Lentiviral Vectors Market, By Product Type (1st-generation, 2nd-generation, and 3rd-generation), By Indication (HIV, β-thalassemia, X-linked Adrenoleukodystrophy, Metachromatic Leukodystrophy, and Wiskott-Aldrich Syndrome), By End User (Hospitals, Clinics, and Research Institutes), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
Lentiviral vectors are potential gene transfer vehicles used in both research and gene therapy applications. Lentiviral vectors have the capacity to stably express a gene of interest in non-dividing and diving cells, which makes them efficient vehicles for gene transfer. Lentiviral vectors are used for the treatment of various rare genetic disorders such as β-thalassemia, X-linked Adrenoleukodystrophy, X-linked severe combined immunodeficiency (SCID-X1) and Metachromatic Leukodystrophy. Moreover, various market players are focusing on increasing their research and development activities for gene therapies including lentiviral vectors, in order to enhance their product portfolio, which is expected to drive growth of the global lentiviral vectors market over the forecast period. For instance, in May, 2019, Avrobio Inc. initiated a phase I/II trial for lentiviral vector gene therapy including AVR-RD-02 for patients with type 1 Gaucher disease.
Market Dynamics
Market players are focusing on adopting various inorganic growth strategies such as agreements, acquisitions, partnerships, and collaborations, in order to strengthen their market presence, which is expected to drive growth of the global lentiviral vectors market over the forecast period. For instance, on April 07, 2020, SIRION Biotech GmbH announced that it entered into an agreement with Beam Therapeutics, a biotechnology company, which is focusing on the use of CRISPR technology for the development of advanced genetic medicines. Under this agreement, SIRION Biotech GmbH provided the non-exclusive access of its proprietary lentiviral transduction enhancer LentiBOOST, to Beam Therapeutics for clinical development and commercialization of CAR-T programs.
Key features of the study:
- This report provides in-depth analysis of the global lentiviral vectors market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global lentiviral vectors market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Thermo Fisher Scientific, Sirion-Biotech GmbH, Vigene Biosciences, OriGene Technologies, Inc., SignaGen Laboratories, Sino Biological Inc., Takara Bio Inc., Cell Biolabs, Inc., GenTarget Inc., GENEMEDI, and bluebird bio, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global lentiviral vectors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lentiviral vectors market
- Global Lentiviral Vectors Market, By Product Type:
- 1st-generation
- 2nd-generation
- 3rd-generation
- Global Lentiviral Vectors Market, By Indication:
- HIV
- β-thalassemia
- X-linked Adrenoleukodystrophy
- Metachromatic Leukodystrophy
- Wiskott-Aldrich Syndrome
- Global Lentiviral Vectors Market, By End User:
- Hospitals
- Clinics
- Research Institutes
- Global Lentiviral Vectors Market, By Region:
- North America
- By Product Type:
- 1st-generation
- 2nd-generation
- 3rd-generation
- By Indication
- HIV
- β-thalassemia
- X-linked Adrenoleukodystrophy
- Metachromatic Leukodystrophy
- Wiskott-Aldrich Syndrome
- By End User:
- Hospitals
- Clinics
- Research Institutes
- By Country:
- U.S.
- Canada
- Latin America
- By Product Type:
- 1st-generation
- 2nd-generation
- 3rd-generation
- By Indication
- HIV
- β-thalassemia
- X-linked Adrenoleukodystrophy
- Metachromatic Leukodystrophy
- Wiskott-Aldrich Syndrome
- By End User:
- Hospitals
- Clinics
- Research Institutes
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Product Type:
- 1st-generation
- 2nd-generation
- 3rd-generation
- By Indication
- HIV
- β-thalassemia
- X-linked Adrenoleukodystrophy
- Metachromatic Leukodystrophy
- Wiskott-Aldrich Syndrome
- By End User:
- Hospitals
- Clinics
- Research Institutes
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Product Type:
- 1st-generation
- 2nd-generation
- 3rd-generation
- By Indication
- HIV
- β-thalassemia
- X-linked Adrenoleukodystrophy
- Metachromatic Leukodystrophy
- Wiskott-Aldrich Syndrome
- By End User:
- Hospitals
- Clinics
- Research Institutes
- By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Product Type:
- 1st-generation
- 2nd-generation
- 3rd-generation
- By Indication
- HIV
- β-thalassemia
- X-linked Adrenoleukodystrophy
- Metachromatic Leukodystrophy
- Wiskott-Aldrich Syndrome
- By End User:
- Hospitals
- Clinics
- Research Institutes
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Product Type:
- 1st-generation
- 2nd-generation
- 3rd-generation
- By Indication
- HIV
- β-thalassemia
- X-linked Adrenoleukodystrophy
- Metachromatic Leukodystrophy
- Wiskott-Aldrich Syndrome
- By End User:
- Hospitals
- Clinics
- Research Institutes
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Thermo Fisher Scientific*
- Company Overview
- Material Portfolio
- Financial Performance
- Key Highlights
- Market Strategies
- Sirion-Biotech GmbH
- Vigene Biosciences
- OriGene Technologies, Inc.
- SignaGen Laboratories
- Sino Biological Inc.
- Takara Bio Inc.
- Cell Biolabs, Inc.
- GenTarget Inc.
- GENEMEDI
- bluebird bio, Inc.
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Indication
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- PEST Analysis
- 4. Global Lentiviral Vectors Market – Impact of Coronavirus (Covid-19) Pandemic
- Pre COVID-19 Market Scenario
- Post COVID-19 Market Scenario
- Overall Impact on Healthcare Market
- Clinical Trial Analysis
- 1. Global Lentiviral Vectors Market, By Product Type, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- 1st-generation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- 2nd-generation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- 3rd-generation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- 2. Global Lentiviral Vectors Market, By Indication, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- HIV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- β-thalassemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- X-linked Adrenoleukodystrophy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Metachromatic Leukodystrophy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Wiskott-Aldrich Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- 3. Global Lentiviral Vectors Market, By End User, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- 4. Global Lentiviral Vectors Market, By Region, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2027
- North America
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- 5. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Thermo Fisher Scientific
- Company Overview
- Device Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sirion-Biotech GmbH
- Company Overview
- Device Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Vigene Biosciences
- Company Overview
- Device Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- OriGene Technologies, Inc.
- Company Overview
- Device Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- SignaGen Laboratories
- Company Overview
- Device Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sino Biological Inc.
- Company Overview
- Device Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Takara Bio Inc
- Company Overview
- Device Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cell Biolabs, Inc.
- Company Overview
- Device Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- GenTarget Inc.
- Company Overview
- Device Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- GENEMEDI
- Company Overview
- Device Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- bluebird bio, Inc.
- Company Overview
- Device Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Analyst Views
- 6. Section
- References
- Research Methodology
- About us and Sales Contact
- *Browse 54 market data tables and 48 figures on "Lentiviral Vectors Market” - Global forecast to 2027
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook